Coagulation Parameters With Albumin in Decompensated Cirrhosis (CoPA-D).

NACompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

July 30, 2023

Primary Completion Date

November 25, 2024

Study Completion Date

November 25, 2024

Conditions
Decompensated Cirrhosis
Interventions
BIOLOGICAL

Albumin

20% human albumin solution infusion, to raise and maintain serum albumin levels above 3.0 g/dl. Human albumin solution will be given to those enrolled in the study having serum albumin levels ≤ 3 g/dl to maintain the serum albumin levels above 3 g/dl.

OTHER

Standard of Care

Standard treatment that the patient would receive had they not been included in the trial.

Trial Locations (1)

110070

Institute of Liver & Biliary Sciences, New Delhi

All Listed Sponsors
lead

Institute of Liver and Biliary Sciences, India

OTHER